CTRI/2022/12/048328
Not yet recruiting
未知
A novel predictive score for assessing the risk of developing Non-Alcoholic Fatty Liver Disease (NAFLD) using biochemical markers
PG Grants, Kasturba Medical College0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: K758- Other specified inflammatory liverdiseases
- Sponsor
- PG Grants, Kasturba Medical College
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria for patients:
- •Adult patients ( \>18 years, both men and women) with primary NAFLD
- •Clinical, biochemical, and imaging\-based diagnosis with or without liver biopsy along with Fibro Scan
- •Patients with features of metabolic syndrome
- •Inclusion criteria for the control population:
- •Adult healthy individuals ( \>18 years of age, both men and women) without NAFLD and any other liver diseases
- •Individuals without features of metabolic syndrome
Exclusion Criteria
- •Exclusion criteria for patients:
- •Alcohol consumption \>25ml/ day for females and \>38ml/ day for males
- •Patients with secondary NAFLD and other liver diseases
- •Pregnant and pediatric population
- •Exclusion criteria for the control population:
- •Patients with abnormal liver function tests for any other reasons other than NAFLD
- •Alcohol consumption \>25ml/ day for females and \>38ml/ day for males
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The new risk scoring system for predicting epithelial ovarian malignancy: Risk of ovarian cancer score (ROCS)Adnexal massOvarian cancerAdnexal mass, Ovarian cancer, Predictive model, Risk scoringTCTR20231103007Srinakharinwirot University124
Completed
Not Applicable
Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction: development and internal validatioContrast-induced nephropathy was defined as the deterioration of renal function following the administration of contrast agents and unlikely to be explained by other possible causes. Patients with anprediction score,contrast-induced nephropathy,STEMITCTR20190705001/A217
Active, not recruiting
Phase 1
Prospective evaluation of the predictive value of a circulating tumor cell (CTC) sensitivity profile to Cisplatin chemotherapy in metastatic breast cancer patientsMetastatic breast cancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-005395-34-NLErasmus MC72
Completed
Not Applicable
Evaluation of cumulative prognostic score based on fibrinogen and albumin in patients with esophageal cancer: multicenter prospective cohort studyJPRN-UMIN000012246Keio University School of Medicine620
Not yet recruiting
Not Applicable
To Validate the Risk Scoring System that is developed by Madras Medical Mission, to predict whether the contrast used during the procedure of angioplasty would result in any alteration of kidney functioCTRI/2014/10/005080The Madras Medical Mission Hospital5,000